Project Details
Description
An interventional efficacy and safety Phase 3 double-blind 2-arm study to investigate IV followed by oral fosmanogepix compared with IV caspofungin followed by oral fluconazole in adult participants with candidemia and/or invasive candidiasis
Status | Active |
---|---|
Effective start/end date | 7/11/24 → 7/10/35 |
Funding
- BASILEA PHARMACEUTICA INTERNATIONAL LTD
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.